Want to join the conversation?
$PHM's number of homes in production at March 31, 2016 was 41% higher than at March 31, 2015. This increase due to a number of factors, including the higher net new order volume and backlog and a decision to purposefully increase the number of unsold homes under construction.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.